Journal of Infectious Diseases, 213(1), 39-48. Oxford University Press Journal of Infectious Diseases, 213(1), 39. Oxford University Press Hermans, L E, Svicher, V, Pas, S D, Salpini, R, Alvarez, M, Ben Ari, Z, Boland, G, Bruzzone, B, Coppola, N, Seguin-Devaux, C, Dyda, T, Garcia, F, Kaiser, R, Köse, S, Krarup, H, Lazarevic, I, Lunar, M M, Maylin, S, Micheli, V, Mor, O, Paraschiv, S, Paraskevis, D, Poljak, M, Puchhammer-Stöckl, E, Simon, F, Stanojevic, M, Stene-Johansen, K, Tihic, N, Trimoulet, P, Verheyen, J, Vince, A, Weis, N, Yalcinkaya, T, Zidovec Lepej, S, Perno, C, Boucher, C A B, Wensing, A M J & HEPVIR working group of the European Society for translational antiviral research (ESAR) 2016, ' Combined Analysis of the Prevalence of drug Resistant Hepatitis B Virus in antiviral therapy Experienced patients in Europe (CAPRE) ', Journal of Infectious Diseases, vol. 213, no. 1, pp. 39-48 . https://doi.org/10.1093/infdis/jiv363